Literature DB >> 30847562

Gestational trophoblastic neoplasms (GTNs) do not display epithelial-to-mesenchymal transition (EMT) features.

Estelle Dubruc1, Fabienne Allias1, Anne Pierre Morel2, François Golfier3, Alain Puisieux2, Mojgan Devouassoux-Shisheboran4,5.   

Abstract

Although epithelial-to-mesenchymal transition (EMT) has been described in the development of complete hydatidiform moles and the invasion of the maternal decidua by trophoblasts during normal human placentation, its implication in gestational trophoblastic neoplasm (GTN) without villi is totally unknown. We studied the immunoexpression of EMT transcription factors (TWIST1, ZEB1, ZEB2), E-cadherin, and vimentin in 18 trophoblastic tumors and pseudo-tumors. Weak nuclear TWIST1 immunostaining was seen in 5% to 10% of all trophoblastic cells, without ZEB1 and ZEB2 nuclear staining. Trophoblastic cells did not express vimentin, and the expression of E-cadherin was maintained in all cases, indicating the absence of EMT features in GTN.

Entities:  

Keywords:  EMT; Gestational trophoblastic neoplasia; PSTT; TWIST1; Trophoblastic tumors; ZEB1

Mesh:

Substances:

Year:  2019        PMID: 30847562     DOI: 10.1007/s00428-019-02551-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  14 in total

1.  Twist modulates human trophoblastic cell invasion via regulation of N-cadherin.

Authors:  York Hunt Ng; Hua Zhu; Peter C K Leung
Journal:  Endocrinology       Date:  2011-12-13       Impact factor: 4.736

2.  An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma.

Authors:  J S Tomlinson; M L Alpaugh; S H Barsky
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

3.  The invasive phenotype of placenta accreta extravillous trophoblasts associates with loss of E-cadherin.

Authors:  C M Duzyj; I A Buhimschi; H Motawea; C A Laky; G Cozzini; G Zhao; E F Funai; C S Buhimschi
Journal:  Placenta       Date:  2015-04-14       Impact factor: 3.481

4.  Differential expression of E-cadherin, β-catenin, and Lewis x between invasive hydatidiform moles and post-molar choriocarcinomas.

Authors:  Jean-Jacques Candelier; Lucien Frappart; Ange Lucien Diatta; Tarik Yadaden; Mamadou-Lamine Cissé; Jean-Marie Afoutou; Jean-Yves Picard; Benoît Mennesson; Rima Slim; Karim Si-Tayeb; Philippe Coullin
Journal:  Virchows Arch       Date:  2013-05-17       Impact factor: 4.064

Review 5.  Molecular mechanisms of epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Jian Xu; Rik Derynck
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

6.  Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.

Authors:  G L Vegh; Z Selcuk Tuncer; V Fulop; D R Genest; S C Mok; R S Berkowitz
Journal:  Gynecol Oncol       Date:  1999-11       Impact factor: 5.482

7.  Novel monoclonal antibodies detect Smad-interacting protein 1 (SIP1) in the cytoplasm of human cells from multiple tumor tissue arrays.

Authors:  Emin Oztas; M Ender Avci; Ayhan Ozcan; A Emre Sayan; Eugene Tulchinsky; Tamer Yagci
Journal:  Exp Mol Pathol       Date:  2010-05-31       Impact factor: 3.362

8.  Aberrant expression of E-cadherin and integrin β-1 in trophoblasts is associated with malignant gestational trophoblastic diseases.

Authors:  Huimin Shu; Hua Chen; Binlie Yang; Zhuolin Chang; Miao Xiong; Weixiang Chen
Journal:  Int J Gynecol Cancer       Date:  2013-05       Impact factor: 3.437

9.  Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases.

Authors:  W C Xue; H C Feng; S W Tsao; K Y K Chan; H Y S Ngan; P M Chiu; C D Maccalman; A N Y Cheung
Journal:  Int J Gynecol Cancer       Date:  2003 Nov-Dec       Impact factor: 3.437

10.  ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.

Authors:  Mansi Bhardwaj; Seema Sen; Anjana Sharma; Seema Kashyap; Kunzang Chosdol; Neelam Pushker; Mandeep Singh Bajaj; Sameer Bakhshi
Journal:  Hum Pathol       Date:  2015-06-10       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.